US Patent 6890518 Compositions of chemically modified insulin
Patent 6890518 was granted and assigned to Nektar (pulminary therapeutics business unit) on May, 2005 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 6890518 Compositions of chemically modified insulin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
